# Research Manitoba

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/research-manitoba/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 89.5 |
| Citations | 227,078 |
| City | Winnipeg |
| Country | CA |
| Description | Research Manitoba is a research organisation in Winnipeg, CA. OpenAlex records 4,039 works and 227,078 citations for it. 977 researchers list it as their most recent affiliation. |
| Homepage | http://researchmanitoba.ca/ |
| OpenAlex ID | https://openalex.org/I2801862240 |
| Region | Manitoba |
| Researchers | 977 |
| ROR ID | https://ror.org/02qrynm70 |
| Type | government |
| Works | 4,039 |

## University papers

- [Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology](https://scholariq.org/papers/toward-an-integrated-clinical-molecular-and-serological-classification-of/)
- [Environmental triggers in IBD: a review of progress and evidence](https://scholariq.org/papers/environmental-triggers-in-ibd-a-review-of-progress-and-evidence/)
- [Clinical Practice Guidelines for the Use of Video Capsule Endoscopy](https://scholariq.org/papers/clinical-practice-guidelines-for-the-use-of-video-capsule-endoscopy/)
- [Global evolution of inflammatory bowel disease across epidemiologic stages](https://scholariq.org/papers/global-evolution-of-inflammatory-bowel-disease-across-epidemiologic-stages/)
- [Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection](https://scholariq.org/papers/infliximab-reduces-endoscopic-but-not-clinical-recurrence-of-crohn-s-disease/)
- [Patient Health Questionnaire-9 scores do not accurately estimate depression prevalence: individual participant data meta-analysis](https://scholariq.org/papers/patient-health-questionnaire-9-scores-do-not-accurately-estimate-depression/)
- [Teduglutide, a novel mucosally active analog of glucagon-like peptide-2 (GLP-2) for the treatment of moderate to severe Crohnʼs disease](https://scholariq.org/papers/teduglutide-a-novel-mucosally-active-analog-of-glucagon-like-peptide-2-glp-2-for/)

## University top topics

Showing 8 of 24.

- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Wheat and Barley Genetics and Pathology](https://scholariq.org/topics/wheat-and-barley-genetics-and-pathology/)
- [HVDC Systems and Fault Protection](https://scholariq.org/topics/hvdc-systems-and-fault-protection/)
- [Real-time simulation and control systems](https://scholariq.org/topics/real-time-simulation-and-control-systems/)
- [Advanced Radiotherapy Techniques](https://scholariq.org/topics/advanced-radiotherapy-techniques/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Food composition and properties](https://scholariq.org/topics/food-composition-and-properties/)
- [High-pressure geophysics and materials](https://scholariq.org/topics/high-pressure-geophysics-and-materials/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.